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Interaction of Bacillus species and Salmonella enterica serovar
Typhimurium in immune or inflammatory signaling
from swine intestinal epithelial cells1
C. C. Aperce,* T. E. Burkey,† B. KuKanich,‡ B. A. Crozier-Dodson,* S. S. Dritz,§
and J. E. Minton*2
*Department of Animal Sciences and Industry, Kansas State University, Manhattan 66506-0201;
†Department of Animal Sciences, University of Nebraska, Lincoln 68583-0908;
‡Department of Anatomy and Physiology, Kansas State University, Manhattan 66506-5802;
and §Department of Diagnostic Medicine/Pathobiology, Kansas State University, Manhattan 66506-5601

ABSTRACT: Previous research evaluated a laboratory strain of Bacillus licheniformis (BL) in a model
swine epithelium and found it exerted antiinflammatory effects on Salmonella enterica serovar Typhimurium
(Sal)-induced secretion of IL-8. The current investigation evaluated the antiinflammatory actions of Bacillus bacteria available commercially as feed additives for
the swine industry. Three isolates were obtained from
the product, 2 Bacillus subtilis (BS1 and BS3) and 1
BL (BL2). Swine jejunal epithelial IPEC-J2 cells were
seeded into wells on permeable membrane supports and
allowed to form confluent monolayers. Treatments included apical pretreatment with BL, BS1, BL2, or BS3
for 17 h without Sal, and the same Bacillus treatments
but with 108 cfu of Sal added in the final hour of Bacillus incubation. Two additional treatments included
negative control wells receiving no bacteria (control)
and positive control wells receiving only Sal (10 total treatments). After bacterial incubation, wells were
washed and fresh medium containing gentamicin was
added. Cells were incubated for an additional 5 h, after which apical and basolateral media were recovered

for determination of IL-8 and bacitracin. In addition,
inserts with epithelial cells that had received Sal were
lysed and lysates were cultured to determine treatment
effects on Sal invasion. Exposure to Sal alone provoked
an increase in IL-8 secretion from IPEC-J2 cells compared with control wells (P < 0.001 for both the apical and basolateral directions). Pretreatment with each
Bacillus isolate followed by challenge with Sal reduced
Sal-induced IL-8 secretion in both the apical and basolateral compartments compared with wells receiving
only Sal (P < 0.001; except for BS3 apical, P < 0.01).
The residual presence of bacitracin could be detected
only in BL2 and BL2+Sal. Fewer Sal colonies could be
cultured from lysates of BL2+Sal than from the Sal,
BS1+Sal, and BS3+Sal treatments (P < 0.001). Results indicate that B. subtilis and BL have the ability to
intervene in secretion of the neutrophil chemoattractant
IL-8 from swine intestinal epithelial cells. This effect on
chemokine secretion by gastrointestinal epithelial cells
in vitro could not be explained solely by reduced invasion of epithelial cells by Sal.
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INTRODUCTION
The growth response of nursery pigs to in-feed antibiotics is well documented (Dritz et al., 2002). To date,
no single additive or class of additives has been identi1
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fied to replace the growth response of nursery pigs to
in-feed antibiotics. However, the search for nonantibiotic replacements continues, with the direct-fed microbials representing a significant portion of that search.
In general, evaluation of direct-fed microbials, at times
referred to as probiotics, has been largely empirical.
Little is actually known to suggest how direct-fed microbials may interact with enterocytes in the presence
of pathogenic organisms that are presumably controlled
(to some extent) by growth-promoting quantities of dietary antibiotics. Bacillus spp. represent a collection
of species that may have potential as direct-fed micro-
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bials. Bacillus bacteria are attractive because of their
well-established ability to sporulate and their tendency
to produce secondary metabolites (US Environmental
Protection Agency, 1997a,b). To that end, our laboratory previously evaluated a laboratory strain of Bacillus licheniformis (BL) in a model swine epithelium
and found it to intervene significantly in Salmonella
enterica serovar Typhimurium (Sal)-induced secretion
of IL-8 from gut epithelial cells (Skjolaas et al., 2007).
Additional preliminary results suggested that the antiinflammatory effects of BL were time dependent (Godsey et al., 2007). The current investigation was undertaken to further evaluate the antiinflammatory actions
of Bacillus spp. in a model swine gut epithelium. We
specifically sought to evaluate these effects using Bacillus bacteria available commercially as direct-fed microbial feed additives for the swine industry.

MATERIALS AND METHODS
Animal Care and Use Committee approval was not
obtained for this study because no animals were used.
The aim of this study was to investigate the interaction of Bacillus bacteria and Sal in immune or inflammatory signaling from swine intestinal epithelial cells.
Our previous investigation was limited to a laboratory
strain of BL (Skjolaas et al., 2007). To gain access to
Bacillus bacteria of relevance to the swine industry, we
isolated strains from a commercial product (BioPlus
2B, Chr. Hansen, Milwaukee, WI) for the current studies.

Bacterial Isolation
A sample of the commercial feed additive (25 g) was
solubilized in 225 mL of sterile water and mixed. A
1-mL quantity of the solution was then diluted in 9 mL
of trypticase soy broth (TSB; MP Biomedicals LLC,
Solon, OH). After an overnight incubation at 37°C,
a trypticase soy agar (TSA; MP Biomedicals) plate
was prepared using the broth and incubated overnight.
Three different types of colonies were isolated. Colonies
were forwarded to a commercial laboratory for identification (Silliker Inc., St. Louis, MO). Specimens 1 and 3
were identified as Bacillus subtilis (hereafter, BS1 and
BS3, respectively). Specimen 2 was identified as BL
(hereafter, BL2).
The Sal and the BL isolates used for additional treatments were the same isolates used previously in our
laboratory (Skjolaas et al., 2007). In brief, the Sal was
isolated from a clinical case of swine enteric disease and
the BL isolate was a laboratory strain obtained commercially [American Type Culture Collection (ATCC),
Manassas, VA].

Growth Curves
The growth behavior of bacterial isolates was important in the design and execution of the experiment,

particularly the growth of sufficient numbers of Bacillus bacteria to distribute among treatments. Growth
curves were established for each bacterial isolate in
TSB. For this purpose, the absorbance of the broth at
600 nm was measured, followed by a standard bacterial plate count. After an overnight incubation at 37°C,
colonies were counted and the bacterial population was
estimated.

Bacterial Sensitivity
The sensitivity of the bacteria to common antibiotics
was assessed using a microplate assay. Bacteria were
cultured on TSA and incubated overnight at 37°C.
Three to 5 colonies were then picked and placed in
distilled water to obtain a turbidity of 0.5 McFarland
turbidity standard (108 cfu). A 100-μL quantity of the
suspension was added to a 9-mL tube of Mueller-Hinton broth, and 50 µL of the final solution was added
in each well of the microplate containing antibiotics
at various dilutions. The plates were incubated for 24
h at 37°C. The smallest antibiotic concentration that
completely inhibited visible growth was considered to
be the minimum inhibitory concentration. Qualitative
data concerning antibiotic sensitivity were used to ensure bacteria cultured out of epithelial cells were Sal
rather than one of the Bacillus spp.

Culture of Epithelial Cells
The swine jejunal epithelial cell line, IPEC-J2, was
used to assess the interaction of Sal and the various Bacillus isolates (Rhoads et al., 1994). Culture conditions
were identical to those described previously (Skjolaas
et al., 2006, 2007), except that IPEC-J2 cells (passages
61 to 70) were cultured in 24-mm, 6-well Costar Snapwells (Corning Inc., Corning, NY) for exactly 7 d before
executing the experiment.

Exposure of IPEC-J2 Cells to Bacteria
Twenty-four hours before the beginning of the experiment, confluent IPEC-J2 cells were washed twice
with PBS and fresh antibiotic-free medium was added.
Bacillus bacteria were grown on TSB to obtain the required concentration.
Design of the bacterial exposure of epithelial cells
was patterned after our previously published study
(Skjolaas et al., 2007). There were 10 treatments, and
this required each replicate of the experiment to occupy 2 culture plates. Eight of the 10 treatments required preexposure of IPEC-J2 in the apical chamber
to a 17-h incubation with Bacillus isolates (108 cfu/
well). There were 4 Bacillus isolates, 3 of which were
from the commercial product (BS1, BL2, and BS3) and
1 of which was the ATCC strain (BL) used previously
(Skjolaas et al., 2007). After 16 h had elapsed, one-half
the wells containing Bacillus bacteria were treated apically with 108 cfu of Sal and the other one-half received
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a similar volume of sterile culture media. To recap, the
8 treatment combinations were BL, BS1, BL2, and BS3
without and with Sal coculture (BL+Sal, BS1+Sal,
BL2+Sal, and BS3+Sal, respectively). The other 2 (of
10 total) treatments were negative control wells receiving no bacteria (Con) and positive control wells receiving only Sal for 1 h. Each run of the experiment was
conducted on 4 separate dates. Within each run, there
were 3 replicate wells for each treatment.
After the 1-h incubation after addition of Sal, all
wells were washed twice by overflooding of PBS to remove the extracellular bacteria. New growth medium
containing 50 µg/mL of gentamicin (Gibco, Grand Island, NY) was added to both the apical and basolateral
wells. Plates were returned to the incubator for an additional 5 h. Finally, the media from both apical and
basolateral compartments were collected and stored for
later IL-8 determination by ELISA as described previously (Skjolaas et al., 2006, 2007). An aliquot of the
medium was also used to determine concentration of
bacitracin (described in detail below).

Sal Invasion into IPEC-J2 Epithelial Cells
After removal of the media, inserts containing IPEC-J2 cells that had received treatment with Sal were
washed twice with PBS, placed in new plates, and
treated with 1 mL of 0.1% Triton X-100. The Triton
X-100 solution was pipetted up and down to disrupt the
epithelial cells thoroughly. Dilutions of the cell lysate
were then applied to TSA plates that contained 250
μg/mL of sulfadimethoxine. All Bacillus isolates had
previously been determined to be sensitive to this antibiotic, whereas our Sal isolate was not. After an overnight incubation at 37°C, colonies were counted and the
number of colony-forming units of Sal per milliliter of
IPEC-J2 lysate was determined.

Bacitracin Assay
Liquid chromatography coupled with electrosprayionization mass spectrometry (LCMS) was used to
determine bacitracin production by the various Bacillus bacteria used in the experiment. Commercial bacitracin was purchased from Sigma-Aldrich (Vetranal,
analytical standard, Riedel-deHaen, Sigma-Aldrich, St.
Louis, MO). Bacitracin standard solutions were prepared by dilution of the commercial bacitracin in Dulbecco’s modified Eagle’s medium/F12 growth medium
(with gentamicin) at the concentrations of 50, 100, 500,
1,000, 5,000, and 10,000 ng/mL. Samples (apical and
basolateral media) were thawed and mixed thoroughly.
Samples and standards were deproteinized by mixing
100 µL of media with 200 µL of methanol (100%). The
mixtures were again mixed well and centrifuged for 5
min at maximum speed (16,100 × g at 4°C). A 200-µL
quantity of the supernatant was then transferred to injection vials for LCMS analysis.

1651

The assay was optimized for bacitracin A only considering that bacitracin A is the predominant form of
bacitracin produced (Konz et al., 1997). Chromatographic separation was performed on a Supelco Discovery C8 column (50 × 2.1 mm × 5 μM; Sigma-Aldrich).
The mobile phase was a mixture of acetonitrile (A) and
0.1% formic acid (B), and was delivered at a flow rate
of 0.4 mL/min under a gradient elution program (0 to
3 min, 5% A:95% B; 3 to 5 min, 30% A:70% B; 5 to 6
min, 5% A:95% B; 6 min to the end, 5% A:95% B) at
room temperature. A delay was observed between each
injection to restore the initial conditions. The qualifying and quantifying ion mass-to-charge ratios (m/z)
used in the mass spectrometry interface were, respectively, 475.1 and 199.2. Settings, data acquisition, and
processing were monitored by the software package
Analyst version 1.5 (Applied Biosystems, Foster City,
CA). The time of retention of bacitracin was approximately 4 min. The results were expressed as counts per
second and were converted to nanograms of bacitracin
per milliliter of media, and then further converted to
nanograms per well.

Sal Sensitivity to Bacitracin
The sensitivity of Sal to bacitracin was established
by a microdilution assay following the guidance of the
Clinical and Laboratory Standards Institute (Wayne,
PA). The commercial bacitracin was diluted 1:2 to create a dilution range from 39 to 20,000 ng/mL and 0.05
mL of each dilution was added into the wells of the
microplate. Salmonella Typhimurium was cultured in
Mueller Hinton cation-adjusted media (BD Diagnostic
Systems, Franklin Lakes, NJ). The broth concentration
was adjusted to 5 × 105 cfu/mL and 0.05 mL of the
broth was added to the various concentrations of bacitracin in the microplate. Plates were incubated for 18 h
and were then read at 590 nm.

Statistical Analyses
Apical and basolateral concentrations of IL-8 were
converted to nanograms per well to account for the difference in volume of the apical (1.5 mL) vs. the basolateral (2.6 mL) chamber. Concentrations of IL-8 in the
apical and basolateral compartments were analyzed using the MIXED procedure (SAS Inst. Inc., Cary, NC).
The model included the fixed effects of treatment, secretion direction (apical or basolateral), and their interaction. Day was included in the model as a random effect. The MIXED procedure was also used to determine
treatment effects for Sal invasion into IPEC-J2 epithelial cells. In this case, treatment was the sole source
of variation in the model. To ensure normality of the
data, raw colony-forming unit values were square root
transformed. Means (and SEM) were back transformed
for presentation of the data. The bacitracin data were
analyzed using the MIXED procedure with treatment
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Table 1. Sample rRNA sequence comparison of specimens obtained from a commercial product with sequences in
a reference library1
Specimen 1
Library database

Specimen 2

Specimen 3

Match, %

Mismatches

Match, %

Mismatches

Match, %

Mismatches

99.93
99.71
99.65
99.50
99.23
99.07
99.05
97.41
96.86
94.65

2
3
3
4
5
7
8
15
17
28

98.1
98.36
98.02
98.18
97.63
97.43
97.52
98.62
98.50
93.35

12
11
13
12
15
16
16
12
12
34

99.99
99.73
99.6
99.59
99.39
99.26
99.19
97.18
96.59
94.16

2
3
3
4
5
7
8
15
17
28

2

Bacillus subtilis subtilis (ATCC 6051)
Bacillus mojavensis
Bacillus subtilis spizizenii (ATCC 6633)
B. subtilis spizizenii (DSM 15029)3
Bacillus atrophaeus
Bacillus amyloliquefaciens
Bacillus vallismortis
Bacillus licheniformis
Bacillus sonorensis
Bacillus oleronius
1

MicroSEQ bacterial library from Applied Biosystems (Foster City, CA; AB_Bacterial500Lib_2.0).
ATCC = American Type Culture Collection (Manassas, VA).
3
DSM = Deutsche Sammlung von Mikroorganismen und Zellkulturen (Braunschweig, Germany).
2

(with or without Sal), secretion direction, and their
interaction in the model. All means are least squares
means ± SEM. Bars depicted in the figures generally
represent the means of 12 observations. Technical difficulties prevented inclusion of the Sal invasion assay
data from one run. Therefore, those means represent
9 observations. Comparisons of means were conducted
only if a main effect or interaction was found to be significant (P < 0.05) in the model. Means were declared
statistically different at P < 0.05.

Specimens 1 (BS1) and 3 (BS3) had similarity scores
with Bacillus subtilis subtilis (ATCC 6051) of 99.93 and
99.99%, respectively (Table 1), and specimen 2 (BL2)
was similar to BL at 98.1%.
The precise alignments of each specimen, with its
closest match, were then analyzed and the results are
summarized in Table 2. The base differences that occur
at the beginning (0 to 100) or at the end (400 to 500) of
the sequence may be due to anomalies in the promoter
attachment and have to be considered with caution.
The differences observed in the interior of the sequence
are more likely to be accurate. Both the BS1 and BS3
specimens exhibited 2 base differences compared with
B. subtilis subtilis (ATCC 6051). In contrast, BL2 had
a greater number of total mismatches (12) when compared with the BL from the library. However, when
looking at the alignment, many of these mismatches occurred at the beginning and end of the sequence (base
numbers 0, 1, 28, 31, 47, 49, 52, and 439).
All phylogenetic analyses clearly assigned the bacteria to the Bacillus genus. Specimens BS1 and BS3
were more precisely identified as part of the B. subtilis
spp. and BL2 was identified as a member of the BL
species.

RESULTS
Identification of Bacterial Specimens
from Commercial Product
The 3 different colonies recovered from the sample
were sent to an accredited testing laboratory for microbiological and molecular (16S rRNA) analyses. The
rRNA derived for the bacterial samples were matched
with the library sequence database to find the closest phylogenetic neighbors. None of the genetic profiles
showed complete similarity with the library database.

Table 2. Location of mismatches of specimens obtained from a commercial product compared with reference sequences1
Base number
Item
Specimen 1
Bacillus subtilis subtilis (ATCC 6051)2
Specimen 2
Bacillus licheniformis
Specimen 3
B. subtilis subtilis (ATCC 6051)

0

R
G
W
T

1

W
T

28

A
C

31

T
C

47

G
T

49

T
G

52

Y
C

138

R
G

159

T
G

175

239

T
C

241

A
G

257

422

R
A

Y
T

439

T
Y

R
A

1
The base number, in the top row, corresponds to the base position where a mismatch was observed. A = adenine; T = thymine; G = guanine;
C = cytosine; R = A or G; W = A or T; Y = C or T.
2
ATCC = American Type Culture Collection (Manassas, VA).
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in the basolateral than in the apical direction (P <
0.05 for control wells and P < 0.001 for wells treated
with Sal). Treatment with both BL isolates (BL and
BL2) decreased basal secretion of IL-8 when compared
with control wells (P < 0.05). Pretreatment with each
Bacillus isolate followed by challenge with Sal reduced
Sal-induced IL-8 secretion in both the apical and basolateral compartments compared with wells receiving
only Sal (P < 0.001; except for BS3 apical, P < 0.01).

Effect of Bacillus Bacteria on Invasion
of Sal into IPEC-J2 Cells
Plate counts of Sal from lysates of cells preexposed to
Bacillus spp. (BL+Sal, BS1+Sal, and BS3+Sal) were
similar to plate counts from cells treated only with Sal
(Figure 2). However, colonies of Sal that could be isolated from epithelial cell lysates in the BL2+Sal treatment
were reduced compared with Sal alone (P < 0.001).

Presence of Bacitracin in Media

Figure 1. Polarized secretion of IL-8 from confluent porcine IPECJ2 intestinal epithelial cells. Secretion into the apical chamber is represented by the shaded bars, whereas secretion into the basolateral
chamber is represented by the solid bars. Bars represent the mean ±
SEM of 12 replicate wells per treatment. Treatments included a control (Con) with media alone, or 17 h apical incubation with 108 cfu/
well of Bacillus licheniformis American Type Culture Collection strain
(BL), Bacillus subtilis commercial isolate 1 (BS1), B. licheniformis
commercial isolate 2 (BL2), or B. subtilis commercial isolate 3 (BS3;
top panel). Additional treatments (bottom panel) included all Bacillus treatments exposed to 1 h of coculture with Salmonella enterica
serovar Typhimurium (Sal) in the final hour of Bacillus incubation
(BL+Sal, BS1+Sal, BL2+Sal, and BS3+Sal) or to S. enterica serovar
Typhimurium for only 1 h (Sal). Media from the apical and basolateral
compartments were removed and discarded. Cells were then washed,
medium containing gentamicin was added, and the cells were returned
to the incubator. After 4 h, the experiment was terminated and media from the apical and basolateral compartments were removed for
determination of IL-8. For analysis of the data, effects of treatment
(Trt), secretion direction (Dir), and their interaction were included
in the model. The numbers above and below the bars represent comparisons among interaction means between and within the Con and
Sal treatments: 1 vs. 2, apical Con vs. apical Sal, P < 0.001; 3 vs. 4,
basolateral Con vs. basolateral Sal, P < 0.001; 5 vs. 6, apical Con vs.
basolateral Con, P < 0.05; 7 vs. 8, apical Sal vs. basolateral Sal, P <
0.001. Letters above and below the bars show comparisons between
Con and other treatments (top panel) or between Sal and other treatments (bottom panel) within apical and basolateral means (a vs. b, P
< 0.001; a vs. c, P < 0.01).

IL-8
In the absence of Bacillus coculture, exposure to Sal
alone provoked an increase in IL-8 secretion from IPECJ2 cells (Figure 1) compared with Con wells (P < 0.001
for both the apical and basolateral directions). Both
unstimulated secretion of IL-8, in Con wells, and stimulated secretion, in wells treated with Sal, were greater

Our original intent was to evaluate bacitracin in media at the conclusion of the incubation after addition
of Sal. Unfortunately, those media were discarded and
only the media recovered at the conclusion of the study
were evaluated for the presence of bacitracin. Bacitracin could be detected only in media from wells that
had previously contained BL2 and BL2+Sal (Figure

Figure 2. Invasion of Salmonella enterica serovar Typhimurium
(Sal) into polarized confluent porcine IPEC-J2 intestinal epithelial
cells. Bars represent the mean ± SEM of 9 replicate wells per treatment. Treatments included apical 108 cfu of Sal alone or 17-h apical
incubation with 108 cfu/well of Bacillus licheniformis American Type
Culture Collection strain (BL), Bacillus subtilis commercial isolate 1
(BS1), B. licheniformis commercial isolate 2 (BL2), or B. subtilis commercial isolate 3 (BS3), and then coculture with Sal during the final
hour of Bacillus incubation. Media from the apical and basolateral
compartments were removed and discarded. Cells were then washed,
medium containing gentamicin was added, and the cells were returned
to the incubator. After 5 h, the experiment was terminated. The IPECJ2 cells were lysed and the lysate was cultured overnight on tryptic soy
agar for the presence of Sal. Colonies of Sal were reduced in BL2+Sal
compared with Sal (a vs. b, P < 0.001). Trt = treatment.
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3). Concentrations of bacitracin were similar for BL2
and BL2+Sal in both the apical and the basolateral
direction.

Sal Sensitivity to Bacitracin
Bacterial growth was observed in all the wells treated
with Sal regardless of the dose of bacitracin tested. The
microplate assay was qualitative, meaning that as long
as bacterial growth resulted in a minimum predetermined level of absorbance, the level of bacitracin in
the well failed to inhibit growth. It is possible that the
greatest concentrations of bacitracin may have inhibited Sal growth, but that reduction would not have been
detected based on the protocol we used.

DISCUSSION
Previous studies demonstrated that a common swine
pathogen of the gastrointestinal tract, Sal, induced a
proinflammatory response in the swine jejunal epithelial cell line IPEC-J2, as evidenced by secretion of the
neutrophil chemoattractant IL-8 (Skjolaas et al., 2006).
Basolaterally polarized secretion of IL-8 has also been
observed in epithelial cell lines from other species (McCormick et al., 1993; Vijay-Kumar et al., 2008). Of
particular relevance to the current study, we previously
reported that secretion of IL-8 from a model swine gastrointestinal epithelium was reduced substantially by
pretreatment with the ATCC 10716 strain of BL (Skjolaas et al., 2007). Although a wide range of inflammatory mediators could have been evaluated in the current study, we evaluated elaboration of IL-8 into the
media owing to its well-documented role in attracting
neutrophils to sites of mucosal inflammation.
In the current study, we sought to investigate Bacillus strains of more direct relevance to the swine industry to evaluate whether the antiinflammatory action
observed with the laboratory strain could be extended
to Bacillus bacteria found in direct-fed microbial preparations. For this, we turned to the feed additive BioPlus
2B. This additive is commercialized for use not only
in pigs, but also in broilers and turkeys. It contains
BL [Deutsche Sammlung von Microorganismen und
Zellkulturen (DSM) 5749] spores isolated from soil and
B. subtilis (DSM 5750) spores isolated from soybean
fermentation. BioPlus 2B contains at least 1.6 × 109
spores/g of each Bacillus that are resistant to flavomycin and zinc-bacitracin. This product is reported to
improve general health, fertility, and BW gain in swine
production systems (Alexopoulos et al., 2004; Jørgensen and Kürti, 2006).
Our effort to obtain Bacillus bacteria from the product resulted in recovery of 3 isolates. The 16S rRNA
genetic analysis revealed the presence of 1 BL (98.1%)
and 2 B. subtilis (99.93 and 99.99%). This is generally
consistent with publically accessible information concerning the bacterial content of the product. However,
the 2 B. subtilis we recovered (BS1 and BS3) differed

Figure 3. Concentration of bacitracin from confluent porcine IPEC-J2 intestinal epithelial cells. Accumulation in the apical chamber is
represented by the shaded bars, whereas secretion into the basolateral
chamber is represented by the solid bars. Bars represent the mean ±
SEM of 12 replicate wells per treatment. Treatments included a control (Con) with media alone or a 17-h apical incubation with 108 cfu/
well of Bacillus licheniformis American Type Culture Collection strain
(BL), Bacillus subtilis commercial isolate 1 (BS1), B. licheniformis
commercial isolate 2 (BL2), or B. subtilis commercial isolate 3 (BS3;
top panel). Additional treatments (bottom panel) included all Bacillus treatments exposed to 1 h of coculture with Salmonella enterica
serovar Typhimurium (Sal) in the final hour of Bacillus incubation
(BL+Sal, BS1+Sal, BL2+Sal, and BS3+Sal) or to S. enterica serovar
Typhimurium for only 1 h (Sal). Media from the apical and basolateral
compartments were removed and discarded. Cells were then washed,
medium containing gentamicin was added, and the cells were returned
to the incubator. After 5 h, the experiment was terminated and media
from the apical and basolateral compartments were removed for determination of concentration of bacitracin. Bacitracin was not detectable
(ND) in media from treatments other than BL2 and BL2+Sal.

by only 4 bases, and 2 of those bases were found at the
extremity of the sequence. The information provided
by the feed additive manufacturer indicated that the
product contained equal amounts of spores from BL
and B. subtilis. It could be that BS1 and BS3 are, in
fact, the same B. subtilis, but given the slight difference
underlined by the RNA analysis, we elected to evaluate
the organisms separately.
In the current investigation, we again confirmed that
the isolate of Sal that we have used in many in vivo
(Balaji et al., 2000; Burkey et al., 2004; Fraser et al.,
2007) and in vitro studies (Skjolaas et al., 2006, 2007)
stimulated polarized secretion of IL-8 from IPEC-J2
cells. This effect has been thoroughly documented in
this swine-derived cell line (Schierack et al., 2006) and
in cell lines from other species (Eckmann et al., 1993;
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McCormick et al., 1993). Of relevance to the major
focus of the current study, we again observed that the
ATCC BL isolate completely inhibited Sal-induced
secretion of IL-8 from IPEC-J2. Similarly, all isolates
from the commercial feed additive behaved similarly
to the ATCC BL isolate in blunting both apical and
basolateral secretion of IL-8, although BS3 was somewhat less effective compared with the other strains. Of
interest, both strains of BL (BL and BL2) even reduced
basal IL-8 secretion from cells not stimulated with Sal.
We had observed a similar effect previously, but only
with Lactobacillus reuteri (Skjolaas et al., 2007).
One hypothesis to explain the ability of Bacillus bacteria to affect inflammatory signaling from enterocytes
in vitro was that Bacillus prevented Sal from attaching and invading into the cell monolayer. To evaluate
this possibility, we cultured lysates of IPEC-J2 after
exposure to Bacillus. When compared with Sal, only
BL2+Sal reduced colonies of Sal that could be recultured out of IPEC-J2 lysates. Although graphically,
the reduction does not appear to be substantial on a
logarithmic scale, it likely indicates a marked decline
in the number of Sal breaching the epithelial barrier in
the BL2+Sal treatment. Although this reduction may
be related to other factors (discussed below), it does
not explain the general ability of Bacillus to reduce secretion of IL-8 under these experimental circumstances
because BL, BS1, and BS3 all reduced IL-8 without
affecting invasion.
Among other secondary secretory components, Bacillus bacteria, including the ATCC BL isolate, are known
to produce the polypeptide antibiotic bacitracin (Konz
et al., 1997). We hypothesized that the ability of Bacillus bacteria, particularly BL, to affect Sal invading
IPEC-J2 cells may simply be related to their ability to
produce bacitracin. As noted previously, our intent was
to measure bacitracin in media collected at the conclusion of the bacterial incubation. Unfortunately, those
media were discarded and only media collected at the
conclusion of the study were available for determination of bacitracin content.
Bacitracin was detected only in media from wells
that had contained BL2, both in the presence and absence of Sal. In our antibiotic sensitivity tests, bacitracin failed to prevent Sal growth at concentrations up to
20 µg/mL. Because we did not measure bacitracin at
the conclusion of the bacterial incubation, we cannot
say with absolute certainty that other BL2 or other
bacilli produced bacitracin at quantities sufficient to
affect the viability of Sal in our cultures. Thus, we must
limit our interpretation and discussion here to account
for the residual presence of bacitracin in the absence of
Bacillus organisms and after thorough washing of wells.
Key to our interpretation, we noted the gross appearance of biofilm associated with cultures of BL2 as we
gained early experience growing the isolate. Bacillus
bacteria are well-known producers of a variety of metabolites, including surfactin. Bacillus subtilis, for example, is known to produce a large array of secondary
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metabolites, such as mycosubtilin, iturin, and surfactin
(Arima et al., 1968; Stein, 2005; Seydlova and Svobodova, 2008). Surfactin is a lipopeptide antibiotic and
a powerful biosurfactant (Singh and Cameotra, 2004;
Rodrigues et al., 2006; Nagorska et al., 2007). Surfactin, among its many properties, exhibits antimicrobial
activities. Therefore, we suggest that BL2-produced
biofilm that was resistant to washing after bacterial
incubation could likely have been the source of passive
evolution of bacitracin in the media in the absence of a
direct source from Bacillus bacteria. Whether sufficient
bacitracin was produced to affect survival of Sal in the
BL2+S treatment cannot be determined from the current data.
Finally, we feel it is important to consider whether
the effects of Bacillus on Sal-induced IL-8 secretion we
have observed here and previously (Skjolaas et al., 2007)
have physiological relevance. Perhaps it could be that
these effects might simply be an artifactual consequence
of the pretreatment with Bacillus bacteria exhausting
the nutrients in the media, leaving the cells less capable
of secreting IL-8. On one hand, the production of bacitracin is generally associated with the early stages of
sporulation in BL (Bernlohr and Novelli, 1959), and
this, coupled with the obvious acidity (yellowing) that
developed in the media by the time Sal were added,
might support such a conclusion. On the other hand,
under identical experimental conditions, a lactic acidproducing bacteria, L. reuteri, produced substantial
acidity in the media, but this condition alone failed to
reduce the ability of Sal to stimulate IL-8 secretion from
IPEC-J2 (Skjolaas et al., 2007). Assuming our findings
have relevance to the function of Bacillus-containing
feed additives within the gastrointestinal tract, an important question that remains relates to the ability of
these bacteria, or any direct-fed microbial, to colonize
the gut in sufficient numbers to affect the interaction
of the epithelium with enteropathogens to explain the
reported benefits of probiotic bacteria.
Results of the current studies indicate that Bacillus
bacteria, at least B. subtilis and BL, have the ability to
intervene in secretion of the neutrophil chemoattractant
IL-8 from swine intestinal epithelial cells. This effect on
chemokine secretion by gastrointestinal epithelial cells
in vitro could not be explained by reduced invasion of
epithelial cells by Sal.
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